SEMPRUS BIOSCIENCES
Semprus BioSciences is a venture-backed biomedical company headquartered in Cambridge, Massachusetts. Our innovative, multi-faceted Semprus technology signifies a breakthrough in medical device technology. Our current focus is to develop a vascular access catheter with the first single surface modification that is designed to simultaneously reduce microbial adherence and thrombus accumulation over the life of the device. In December 2010, the company completed an $18 million Series B financing ... co-led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners (FMP), a national healthcare venture capital investment firm with a strategic relationship with Cleveland Clinic. Combined with previous financing rounds, Semprus has raised a total of $28.5 million in equity.
SEMPRUS BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2006-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.semprusbio.com
Total Employee:
11+
Status:
Closed
Contact:
6175777756
Email Addresses:
[email protected]
Total Funding:
27 M USD
Technology used in webpage:
Google Maps Microsoft Azure DNS Mimecast Network Solutions CSC Global DNS
Similar Organizations
Immutrix Therapeutics
Immutrix Therapeutics is a medical tech company that has developed a medical device for cleansing the blood.
Thinks Works
Thinks Works is an early-stage biomedical company developing ideas and products for improvement in the treatment of scoliosis.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pangaea Ventures
Pangaea Ventures investment in Series B - Semprus BioSciences
Foundation Medical Partners
Foundation Medical Partners investment in Series B - Semprus BioSciences
5AM Ventures
5AM Ventures investment in Series B - Semprus BioSciences
SR One
SR One investment in Series B - Semprus BioSciences
GlaxoSmithKline
GlaxoSmithKline investment in Series B - Semprus BioSciences
5AM Ventures
5AM Ventures investment in Series A - Semprus BioSciences
Pangaea Ventures
Pangaea Ventures investment in Series A - Semprus BioSciences
Official Site Inspections
http://www.semprusbio.com
- Host name: vux.bos.netsolhost.com
- IP address: 205.178.145.65
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258